Veletri and Glipizide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Veletri (epoprostenol sodium) and Glipizide (glipizide). Common drug interactions include acute sinusitis among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Veletri and Glipizide. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Veletri?

Veletri has active ingredients of epoprostenol sodium. eHealthMe is studying from 14,196 Veletri users. Check the latest studies of Veletri.

What is Glipizide?

Glipizide has active ingredients of glipizide. It is often used in diabetes. eHealthMe is studying from 64,852 Glipizide users. Check the latest studies of Glipizide.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 17, 2026

29 people who take Veletri and Glipizide together, and have interactions are studied.

Veletri and Glipizide drug interactions.

What are the common drug interactions of Veletri and Glipizide, by gender? *:

female:

Acute sinusitis
Arthralgia (joint pain)
Arthropathy
Blood alkaline phosphatase increased
Blood calcium increased
Blood glucose increased
Blood parathyroid hormone increased
Bone pain
Crying
Decreased appetite

male:

Dyspnoea (difficult or laboured respiration)
Loss of consciousness
Platelet count decreased
Pyrexia (fever)
Somnolence (a state of near-sleep, a strong desire for sleep)
Subdural haematoma (blood collects between the skull and the surface of the brain)
Thrombocytopenia (decrease of platelets in blood)
Cardiac failure congestive
Fluid overload (too much fluid in the blood)
Blood lactic acid increased

What are the common drug interactions of Veletri and Glipizide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Acute respiratory distress syndrome
Back pain
Blood creatinine increased
Blood potassium decreased
Blood urea increased
Cellulitis (infection under the skin)
Constipation
Decreased activity
Dehydration (dryness resulting from the removal of water)
Diarrhoea

50-59:

Ascites (accumulation of fluid in the abdominal cavity)
Asthenia (weakness)
Blood bilirubin increased
Gallbladder enlargement
Haemoglobin decreased
Liver disorder (liver diseases)
Muscular weakness (muscle weakness)
Platelet count decreased
Somnolence (a state of near-sleep, a strong desire for sleep)
Subdural haematoma (blood collects between the skull and the surface of the brain)

60+:

Dyspnoea (difficult or laboured respiration)
Loss of consciousness
Arthropathy
Back pain
Blood alkaline phosphatase increased
Blood calcium increased
Blood glucose increased
Blood parathyroid hormone increased
Bone pain
Chills (felling of cold)

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 28 people, 96.55%
Portopulmonary Hypertension (coexistence of portal and pulmonary hypertension): 5 people, 17.24%
Pain: 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Veletri and Glipizide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously